Capital Fund Management S.A. Vertex Pharmaceuticals Inc Put Options Transaction History

Capital Fund Management S.A.

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 13, 2024	BUY	$460.0 - $505.78 $5.29 Million - $5.82 Million	11,500 New	11,500 $5.35 Million
Q1 2024 May 15, 2024	BUY	$407.69 - $446.08 $5.5 Million - $6.02 Million	13,500 New	13,500 $5.64 Million
Q3 2023 Nov 14, 2023	BUY	$338.18 - $362.46 $14 Million - $15 Million	41,300 New	41,300 $14.4 Million
Q1 2020 May 13, 2020	BUY	$199.77 - $247.81 $799,080 - $991,240	4,000 Added 160.0%	6,500 $1.55 Million
Q4 2017 Feb 09, 2018	SELL	$137.28 - $155.55 $302,016 - $342,210	-2,200 Reduced 46.81%	2,500 $375,000
Q3 2017 Nov 13, 2017	BUY	$148.13 - $162.24 $696,211 - $762,528	4,700	4,700 $715,000

1,724

221M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.